Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia

Keyphrases

• Tardive Dyskinesia 100%
• Levodopa-induced Dyskinesia 100%
• Drug-induced Dyskinesia 100%
• Tardive Syndrome 100%
• Disease Syndrome 50%
• Treatment Strategy 50%
• Dopamine 50%
• Dopamine Receptor 50%
• Preventive Measures 50%
• Phenomenology 50%
• Offending 50%
• Dystonia 50%
• Drug Type 50%
• Patients with Parkinson's Disease 50%
• Dyskinesia 50%
• Receptor Blocking 50%
• Botulinum Neurotoxin (BoNT) 50%
• Offending Drugs 50%
• Motor Fluctuations 50%
• Chorea 50%
• Deep Brain Stimulation 50%
• Tetrabenazine 50%
• Focal Dystonia 50%
• Tardive Dystonia 50%
• Akathisia 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Dyskinesia 100%
• Tardive Dyskinesia 100%
• Syndrome 66%
• Levodopa-Induced Dyskinesia 66%
• Dystonia 66%
• Disease 33%
• Dopamine Receptor 33%
• Parkinson's Disease 33%
• Antipsychotic 33%
• Chorea 33%
• Clostridium Botulinum Type A 33%
• Tetrabenazine 33%
• Focal Dystonia 33%
• Akathisia 33%